Exelixis, Inc. (EXEL) Management presents at William Blair 39th Annual Growth Stock Conference (Transcript) [Seeking Alpha]
Exelixis, Inc. (EXEL)
Last exelixis, inc. earnings: 2/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.exelixis.com/phoenix.zhtml?c=120923&p=irol-mediaresources
Company Research
Source: Seeking Alpha
Exelixis, Inc. (EXEL) Management presents at William Blair 39th Annual Growth Stock Conference (Transcript) Exelixis, Inc. (NASDAQ: EXEL Company Participants Chris Senner - Chief Financial Officer Andrew Peters - V.P. of Strategy Conference Call Participants Operator Okay. I think we’ll get started. I like to welcome you all to our 39th Annual Growth Stock Conference, and we are very pleased to have the management team of Exelixis to present and tell us story for us. Given the name Growth Stock Conference, if you were to pick a growth stock in the bio-tech sector this is a prime example, highlighted by their 150% topline growth in 2017, followed by another 75% plus growth topline in 2018. We’ve been covering the story for a long time. We first initiated 12 years ago on the name, so we do have a long track record of following the company. So without further ado, I’ll pass it on the CFO of the company, Chris Senner. Thanks, Andy. So we’ve got a slightly different format today. We're goi
Show less
Read more
Impact Snapshot
Event Time:
EXEL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EXEL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EXEL alerts
High impacting Exelixis, Inc. news events
Weekly update
A roundup of the hottest topics
EXEL
News
- Pheochromocytoma Pipeline Insight Report 2024, Featuring Genentech, Exelixis, Advanced Accelerator Applications, Enterome, FUJIFILM Toyama Chemical, Ipsen, Pfizer and Astex Pharmaceuticals [Yahoo! Finance]Yahoo! Finance
- Institutional investors in Exelixis, Inc. (NASDAQ:EXEL) lost 3.8% last week but have reaped the benefits of longer-term growth [Yahoo! Finance]Yahoo! Finance
- Exelixis to Release First Quarter 2024 Financial Results on Tuesday, April 30, 2024Business Wire
- Global Liver Cancer Drug Market Size To Worth USD 7.6 Billion By 2033 | CAGR Of 10.90% [Yahoo! Finance]Yahoo! Finance
- Exelixis slips as Barclays downgrades on lack of catalysts [Seeking Alpha]Seeking Alpha
EXEL
Earnings
- 2/6/24 - Beat
EXEL
Sec Filings
- 4/18/24 - Form ARS
- 4/18/24 - Form DEFA14A
- 4/18/24 - Form DEF
- EXEL's page on the SEC website